A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing
- PMID: 8070609
- DOI: 10.2337/diab.43.9.1096
A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing
Abstract
The precise nature of the insulin-binding site of the insulin receptor (IR) has not been determined, although the importance of several regions of the alpha-subunit in insulin binding has been demonstrated. A naturally occurring mutation in a patient with severe insulin resistance that changes the Ser323 codon in the alpha-subunit of the IR to a leucine codon is associated with markedly impaired insulin binding to cells from the patient and to transfected cells expressing the mutant receptor. However, unlike other IR alpha-subunit mutations associated with decreased insulin binding, this mutation does not lead to a defect in posttranslational processing or cell-surface expression of IRs. Thus, the defect in insulin binding associated with the Leu323 mutant IR is a direct result of an alteration in the insulin-binding site. No natural IR mutation described thus far is associated with both decreased insulin binding and normal cell-surface expression of the mutant receptor. This study demonstrates the critical role that Ser323 of the IR alpha-subunit plays in insulin binding, either by forming part of the binding site or by stabilizing its conformation.
Similar articles
-
An insulin receptor mutant (Asp707 --> Ala), involved in leprechaunism, is processed and transported to the cell surface but unable to bind insulin.J Biol Chem. 1996 Aug 2;271(31):18719-24. doi: 10.1074/jbc.271.31.18719. J Biol Chem. 1996. PMID: 8702527
-
Structural basis by which a recessive mutation in the alpha-subunit of the insulin receptor affects insulin binding.J Biol Chem. 1994 May 27;269(21):14912-8. J Biol Chem. 1994. PMID: 8195122
-
Replacements of leucine 87 in human insulin receptor alter affinity for insulin.J Biol Chem. 1995 Sep 15;270(37):22017-22. doi: 10.1074/jbc.270.37.22017. J Biol Chem. 1995. PMID: 7665623
-
Mutations in insulin-receptor gene in insulin-resistant patients.Diabetes Care. 1990 Mar;13(3):257-79. doi: 10.2337/diacare.13.3.257. Diabetes Care. 1990. PMID: 1968373 Review.
-
Mutations in the insulin receptor gene.Endocr Rev. 1992 Aug;13(3):566-95. doi: 10.1210/edrv-13-3-566. Endocr Rev. 1992. PMID: 1330507 Review. No abstract available.
Cited by
-
Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy.Diabetes. 2020 Nov;69(11):2481-2489. doi: 10.2337/db20-0345. Epub 2020 Aug 17. Diabetes. 2020. PMID: 32816962 Free PMC article.
-
Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.Protein Sci. 2000 Feb;9(2):310-24. doi: 10.1110/ps.9.2.310. Protein Sci. 2000. PMID: 10716183 Free PMC article.
-
Two novel insulin receptor gene mutations in a patient with Rabson-Mendenhall syndrome: the first Korean case confirmed by biochemical, and molecular evidence.J Korean Med Sci. 2012 May;27(5):565-8. doi: 10.3346/jkms.2012.27.5.565. Epub 2012 Apr 25. J Korean Med Sci. 2012. PMID: 22563226 Free PMC article.
-
Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: a 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462.Hum Genet. 1995 Feb;95(2):174-82. doi: 10.1007/BF00209397. Hum Genet. 1995. PMID: 7860063
-
A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors.Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11692-7. doi: 10.1073/pnas.94.21.11692. Proc Natl Acad Sci U S A. 1997. PMID: 9326672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
